Robert Rifkin
7PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 11, 2024
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.Sikander Ailawadhi, Hans C Lee, James Omel
|Oct 09, 2023
<i>In</i>-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma.Robert M Rifkin, Caitlin L Costello, Ruemu E Birhiray
|Sep 19, 2023
In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management.Robert M Rifkin, Saulius K Girnius, Stephen J Noga
|Feb 13, 2023
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma.Barry Paul, Michaela Liedtke, Jack Khouri
|Oct 29, 2020
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM Registry.Rafat Abonour, Robert M Rifkin, Cristina Gasparetto
|Aug 06, 2019
Development of a prognostic model for overall survival in multiple myeloma using the Connect<sup>®</sup> MM Patient Registry.Howard R Terebelo, Rafat Abonour, Cristina J Gasparetto
Pageof 2
Frequent Collaborators
2 joint publications
Howard R Terebelo
2 joint publications
Sikander Ailawadhi
2 joint publications
Joshua Richter
1 joint publications
Rafat Abonour
1 joint publications
Hans C Lee
1 joint publications
Sundar Jagannath
1 joint publications
Barry Paul
1 joint publications
Michaela Liedtke
1 joint publications
Jack Khouri
1 joint publications
Mitul D Gandhi
